ConductScience.org, home

Paper21292829

The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.

Becker MA and 4 others. Mol Endocrinol, 2011. Cited by 89 papers, by iCite.

Cite this record

ConductScience Library. The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells. Papers, record 21292829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21292829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.
PubMed
Journal
Mol Endocrinol
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
2.23
iCite
Revised in PubMed
2022-08-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Becker MAMarc A
2Ibrahim YHYasir H
3Cui XXiaojiang
4Lee AVAdrian V
5Yee DDouglas

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Estrogen Receptor alphaMajor topic
Insulin-Like Growth Factor IMajor topic
Ribosomal Protein S6 Kinases, 70-kDaMajor topic
Blotting, Western
Breast Neoplasms
Cell Line, Tumor
Cell Proliferation
Chromatin Immunoprecipitation
Humans
Immunoprecipitation
Phosphorylation
Protein Binding
Reverse Transcriptase Polymerase Chain Reaction

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA074285NCI NIH HHSUnited StatesR01CA074285PubMed and NIHNIH RePORTER
R01CA74285NCI NIH HHSUnited StatesR01CA074285PubMed and NIHNIH RePORTER
P30077598PHS HHSUnited StatesPubMedPubMed

Download CSV of grants

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114734488Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance.Clin Cancer Res2004https://conductscience.org/library/papers/14734488PubMed
21958506Tissue culture conditions determine the effects of estrogen and growth factors on the anchorage independent growth of human breast cancer cell lines.J Steroid Biochem Mol Biol1991https://conductscience.org/library/papers/1958506PubMed
38641283Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.EMBO J1996https://conductscience.org/library/papers/8641283PubMed
47838153Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor.Mol Endocrinol1994https://conductscience.org/library/papers/7838153PubMed
58206951Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer.J Biol Chem1994https://conductscience.org/library/papers/8206951PubMed
611509655Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.Mol Cell Biol2001https://conductscience.org/library/papers/11509655PubMed
712554765
Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Mol Endocrinol2003https://conductscience.org/library/papers/12554765PubMed
810777546Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line.J Biol Chem2000https://conductscience.org/library/papers/10777546PubMed
911297505Regulation of translation initiation by FRAP/mTOR.Genes Dev2001https://conductscience.org/library/papers/11297505PubMed
10714108Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.N Engl J Med1978https://conductscience.org/library/papers/714108PubMed
1117805960Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables.Breast Cancer Res Treat2008https://conductscience.org/library/papers/17805960PubMed
122484720Estrogen induces insulin-like growth factor-I expression in the rat uterus.Mol Endocrinol1987https://conductscience.org/library/papers/2484720PubMed
1319138696Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.Steroids2009https://conductscience.org/library/papers/19138696PubMed
147689695
Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
Mol Endocrinol1993https://conductscience.org/library/papers/7689695PubMed
157491495Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.Science1995https://conductscience.org/library/papers/7491495PubMed
1618216219Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.Endocr Rev2008https://conductscience.org/library/papers/18216219PubMed
177677754Mutant IGF-I receptors as dominant negatives for growth and transformation.Biochem Biophys Res Commun1995https://conductscience.org/library/papers/7677754PubMed
189545345Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.J Biol Chem1998https://conductscience.org/library/papers/9545345PubMed
197693722Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.J Cell Physiol1993https://conductscience.org/library/papers/7693722PubMed
2010188734Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells.Int J Cancer1999https://conductscience.org/library/papers/10188734PubMed

See all 81 referencesDownload CSV of references

Cited by73

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
41799434Insulin-like growth factor 1 receptor (IGF1R)-dependent signaling regulates blastocyst formation during early embryonic development.Front Cell Dev Biol2026https://conductscience.org/library/papers/41799434PubMed
40905691Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.Clin Cancer Res2025https://conductscience.org/library/papers/40905691PubMed
38779416Estrogen Receptor Is Required for Metformin-Induced Apoptosis in Breast Cancer Cells Under Hyperglycemic Conditions.Breast Cancer (Auckl)2024https://conductscience.org/library/papers/38779416PubMed
38737496Association of Overweight and Inflammatory Indicators with Breast Cancer: A Cross-Sectional Study in Chinese Women.Int J Womens Health2024https://conductscience.org/library/papers/38737496PubMed
38255823Effects of Melatonin, GM-CSF, IGF-1, and LIF in Culture Media on Embryonic Development: Potential Benefits of Individualization.Int J Mol Sci2024https://conductscience.org/library/papers/38255823PubMed
36610717Suppression of Insulin Receptor Substrate 1 Inhibits Breast Cancer Growth In Vitro and in Female Athymic Mice.Endocrinology2023https://conductscience.org/library/papers/36610717PubMed
36556357The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target.Life (Basel)2022https://conductscience.org/library/papers/36556357PubMed
36107319Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer.Adv Exp Med Biol2022https://conductscience.org/library/papers/36107319PubMed
36093095Biological effects and regulation of IGFBP5 in breast cancer.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36093095PubMed
36085535Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany.Breast Cancer Res Treat2022https://conductscience.org/library/papers/36085535PubMed
35879299Beyond controlling cell size: functional analyses of S6K in tumorigenesis.Cell Death Dis2022https://conductscience.org/library/papers/35879299PubMed
35665642Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma.Mol Cancer Res2022https://conductscience.org/library/papers/35665642PubMed
34959971Consumption of Dairy Products and the Risk of Developing Breast Cancer in Polish Women.Nutrients2021https://conductscience.org/library/papers/34959971PubMed
34209750Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34209750PubMed
33829018Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer.Front Cell Dev Biol2021https://conductscience.org/library/papers/33829018PubMed
33816477Growth Hormone/Insulin Growth Factor Axis in Sex Steroid Associated Disorders and Related Cancers.Front Cell Dev Biol2021https://conductscience.org/library/papers/33816477PubMed
33803410Lifetime Impact of Cow's Milk on Overactivation of mTORC1: From Fetal to Childhood Overgrowth, Acne, Diabetes, Cancers, and Neurodegeneration.Biomolecules2021https://conductscience.org/library/papers/33803410PubMed
32810922Upregulation of CIP2A in estrogen depletion-resistant breast cancer cells treated with low-dose everolimus.FEBS Open Bio2020https://conductscience.org/library/papers/32810922PubMed
32592004Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.Horm Cancer2020https://conductscience.org/library/papers/32592004PubMed
32210584ERα, A Key Target for Cancer Therapy: A Review.Onco Targets Ther2020https://conductscience.org/library/papers/32210584PubMed

See all 73 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
IGF1R3480PubTator's text mininghttps://conductscience.org/library/genes/3480NCBI Gene
IRS13667PubTator's text mininghttps://conductscience.org/library/genes/3667NCBI Gene
IRS28660PubTator's text mininghttps://conductscience.org/library/genes/8660NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
RPS6KB16198PubTator's text mininghttps://conductscience.org/library/genes/6198NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21292829

GET https://conductscience.org/api/papers/v1/21292829/references?page=2